Genelux
long lasting tumor specific cell response corresponds to tumor reduction | Genelux
Company
Deck Type
Sector
Industry
Deck date
October 2023
Slide
37 of 38
Similar slides by Genelux
See diffirences between slides (animation)
Investor Presentation
February 2024
long lasting tumor specific cell response corresponds to tumor reduction | Genelux
Investor Presentation
December 2023
long lasting tumor specific cell response corresponds to tumor reduction | Genelux
Investor Presentation
July 2023
long lasting tumor specific cell response corresponds to tumor reduction | Genelux
Related slides by other companies
AstraZeneca
Investor Event
December 2022
| AstraZeneca
Mink Therapeutics
Investor Day
November 2022
| Mink Therapeutics
Other recent decks by Genelux
See all presentations (4 decks)
Investor Presentation
February 2024
Investor Presentation
December 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io